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Abstract
Background: Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary colon cancer syndrome
caused by mutations in adenomatous polyposis coli (APC) with both colonic and extra-colonic manifestations. Case
reports have noted an association with FAP and intellectual disability and animal studies have shown that APC is
implicated in neural development and function, but no studies have investigated neuropsychological, behavioral, or
structural brain characteristics of patients with FAP.
Methods: We undertook a pilot, sibling-pair study comparing three patients with FAP to their sex-matched siblings
without FAP. Each sibling pair underwent neuropsychological testing by a blinded examiner, high resolution brain
MRI scans, and the mother of each pair rated her children’s adaptive life skills and behavioral and emotional
characteristics. Given the small number of study participants in this pilot study, quantitative comparisons of results
were made by subtracting the score of the non-FAP sibling from the FAP patient on the various
neuropsychological tests and parent rating questionnaires to calculate a difference, which was then divided by the
standard deviation for each individual test to determine the difference, corrected for the standard deviation.
Diffusion numbers in multiple regions of the brain as assessed by MRI were calculated for each study participant.
Results: We found similarity between siblings in all three pairs on a wide range of neuropsychological measures
(general intelligence, executive function, and basic academic skills) as tested by the psychologist as well as in
descriptions of adaptive life skills as rated by mothers. However, mothers’ ratings of behavioral and emotional
characteristics of two of the three pairs showed differences between the siblings, specifically that the patients with
FAP were found to have more behavioral and emotional problems compared to their siblings. No differences in
brain structure were identified by MRI.
Conclusion: We report the first study exploring neuropsychological, behavioral, emotional, and structural brain
characteristics of patients with FAP and found subjective differences as assessed by maternal perception in
behavioral and emotional characteristics in patients with FAP compared to their siblings. Larger studies are needed
to elucidate the relationship, if any, between FAP and brain function.
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Background
Familial adenomatous polyposis (FAP) is an autosomal
dominant hereditary colon cancer syndrome characterized
by 100 or more premalignant polyps caused by germline
mutations in the tumor suppressor gene, adenomatous
polyposis coli (APC), located on chromosome 5q21-q22
[1, 2]. While there is near-complete penetrance of the co-
lonic manifestations, there is variable penetrance of the
extra-colonic manifestations of the disease and the loca-
tion of the mutation within the APC gene is associated
with the severity of colonic polyposis, the degree of cancer
risk, the age of cancer onset, survival, and the presence
and frequency of extra-colonic manifestations [3].
Case reports have linked FAP to the presence of intellec-
tual disability (formerly called mental retardation) [1, 4–
10]. In each of these cases, the individuals had a deletion of
all or a portion of chromosome 5q, but the nature of the in-
tellectual disability was poorly defined and it remained un-
clear whether the intellectual disability was secondary to
loss of APC gene function or another genetic defect due to
the chromosomal loss. APC is known to be involved in
regulating a variety of cellular processes, including mitosis,
cytoskeletal dynamics, axonogenesis, cell polarity and apop-
tosis [11–14] and is central to the WNT signaling pathway,
mediating the destruction of cytoplasmic β-catenin protein
[15]. The APC protein has also been found to be an essen-
tial regulator, in vivo, of synaptic density, maturation and
signal transduction networks in forebrain neurons [16].
Furthermore, studies in mice with a mutated APC gene
have shown learning and memory impairments, autistic-
like behaviors, increased repetitive behaviors, reduced social
interest, increased locomotor activity as well as abnormal
brain morphology and function [16, 17].
In our work caring for multiple families with FAP, we
have made the informal observation that FAP-affected in-
dividuals appear to have more cognitive and social-
emotional difficulties than their non-affected relatives, but
this clinical observation has not been verified with formal
testing. Determining whether cognitive or behavioral prob-
lems are part of the phenotypic spectrum of FAP clearly
has important clinical implications and early recognition of
these issues would allow for interventions to potentially
mitigate the problems. We, therefore, undertook a pilot
sibling-pair study with the aim of assessing feasibility of
identifying differences in neuropsychological performance,
social-emotional characteristics, and of brain morphology
assessed with high resolution MRI, of individuals with and




Three FAP families were selected to participate in the
study, based on convenience. In each family, two young
adult siblings of the same sex, who were within seven
years of age of one another, one with confirmed FAP
and the other with negative germline testing for FAP,
comprised the sibling pair. Each sibling pair shared the
same biological parents and grew up in the same house-
hold. The siblings underwent a comprehensive battery of
neuropsychological testing as well as high resolution
MRI of the brain. The mother of each sibling pair com-
pleted a set of questionnaires describing her children’s
adaptive life skills and social- emotional characteristics.
All study participants underwent informed consent and
this study was approved by the Institutional Review
Board of the University of California, San Francisco
(UCSF).
MRI Technique
All MRI scans were performed on a GE 3T MR scanner
(General Electric Healthcare) with an eight-channel
phase array head coil and included volumetric T1 images
(inversion recovery prepared fast spoiled gradient-
recalled echo, TR = 11.58 ms, TE = 4.8 ms, inversion
time = 450 ms, partition size = 0.895 mm, in-plane reso-
lution = 0.41 mm], T2 images (volumetric fast spin-echo,
TR = 4.0 s, TE = 104 ms, contiguous 1.5-mm sections,
in-plane resolution =0.94 mm]. High-angular resolution
diffusion MRI (HARDI) data were acquired for DTI ana-
lyses (b = 2000 s/mm2, 55 directions, TR/TE = 15,000/
74 ms, 2-mm isotropic voxels). HARDI data were proc-
essed with a weighted least-squares fit to compute the
diffusion tensor metrics. ROIs were drawn on the loca-
tions that correspond to anterior corona radiata and
posterior corona radiata and in the larger surrounding
left and right anterior frontal white matter and left and
right posterior parieto-occipital white matter regions,
the genu and splenium of the corpus callosum, and bi-
lateral cingulum.
Neuropsychological tests and parent rating questionnaires
Baseline demographic data and medical and family his-
tory were obtained on all of the participants. A psych-
ologist (RJJ) blinded to the study participants’ medical
history examined all sibling pairs and administered tests
of general intelligence (Wechsler Abbreviated Scale of
Intelligence-Second Edition - WASI-II) [18], executive
function (Delis-Kaplan Executive Function System - D-
KEFS) [19], and basic academic skills (Wechsler Individ-
ual Achievement Test-Third Edition - WIAT-III) [20].
The mothers of the sibling pairs rated their children on
questionnaires of adaptive life skills (Vineland Adaptive
Behavior Scales, Second Edition - Vineland-II-Parent/
Caregiver Rating Form) [21] and social-emotional char-
acteristics (Vineland-II and ASEBA Adult Behavior
Checklist for Ages 18–59 - ABCL/18-59) [22].
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Data analysis
All of the tests administered yielded standardized age-
normalized scores, though each test had its own mean and
standard deviation (SD) - for example, for the WASI-II the
mean was 100 and SD was 15 and for the D-KEFS the
mean was 10 and SD was 3. Furthermore, a higher score in-
dicated better functioning on some measures but poorer on
others. Consequently, the absolute scores were not directly
comparable across the measures. Given the small number
of study participants in this pilot study and the many mea-
sures, we did not perform statistical analyses of the differ-
ences between the siblings. Instead, we focused on the
pattern of the quantitative within sibling-pair differences in
scores on the many measures by constructing a common
metric: units of standard deviation of within-sibling pair dif-
ference. Specifically, for each pair of siblings we calculated
the difference between their standardized scores on the
given measure and divided the difference by the standard
deviation of that measure. For example, on the VCI (Verbal
Comprehension Index) of the WASI-II test that had a
standard deviation of 15 and a higher score was consistent
with better function, the patient with FAP of family 1
scored 76 while the sibling without FAP scored 81, corre-
sponding to a within-sibling pair difference of −0.33 SD. A
standard deviation score less than zero indicated that the
sibling with FAP showed poorer functioning than the sib-
ling without FAP. Diffusion numbers (average diffusivity,
fractional anisotropy, radial and axial diffusivity) in multiple
regions of the brain as assessed by MRI were calculated for
each study participant.
Results
Clinical and genetic profiles
Family 1
The proband was a 20-year-old Caucasian woman who
underwent genetic testing at the age of seven due to a
family history of FAP and tested positive for the known
family APC Q1045X mutation. Her first colonoscopy
was performed at the age of ten and multiple sessile ad-
enomas were found throughout the colon. The patient is
screened annually with upper endoscopy and colonos-
copy and has not yet had prophylactic colectomy. Her
paired sibling was her 27-year-old sister, who had nega-
tive genetic testing for the family mutation at age ten. A
pedigree is shown in Fig. 1.
Family 2
The proband was a 26-year-old man with mixed Hispanic,
European and Native American ancestry who underwent
genetic testing for FAP at the age of seven due to a family
history of FAP and tested positive for the known APC
N1124X mutation. This patient had a total restorative
proctocolectomy with ileoanal J-pouch at the age of eight.
His paired sibling was his 24-year-old brother, who had
negative genetic testing for the family mutation at the age
of nine. A pedigree is shown in Fig. 1.
Family 3
The proband was a 21-year-old woman of mixed Asian,
European, and Hispanic ancestry who was diagnosed
with FAP at the age of 16 after endoscopy two years
earlier for hematochezia, anemia and weight loss re-
vealed greater than 100 gastric polyps and greater than
200 colonic polyps. Genetic testing for FAP was positive
for the APC S457X mutation. She underwent total col-
ectomy with ileal pouch-anal anastomosis at the age of
19. Her father was subsequently diagnosed with FAP
and he tested positive for the known family APC S457X
mutation. Her paired sibling was her 20-year-old sister,
who had negative genetic testing for the family mutation
at age 18. A pedigree is shown in Fig. 1.
Results of neuropsychological testing and of parental
ratings of adaptive, behavioral, and emotional
characteristics
The results of neuropsychological testing of the sibling
pairs are shown in Fig. 2. The sibling pairs scored simi-
larly on the WASI-II (general intelligence), D-KEFS (ex-
ecutive function), and WIAT-III (academic skills) tests,
with only a single notable difference in family 2, where
the patient with FAP scored five points lower than his
sibling pair on the design fluency portion of the D-KEFS
test, corresponding to a difference of 1.67 standard devi-
ations. In contrast, the mothers’ rating of their children
did show differences. The results of questions related to
adaptive life skills measured by the Vineland-II are
shown in Fig. 2. Overall, there was a trend towards the
mothers’ rating their child with FAP with poorer scores
compared to their child without FAP. This was most no-
ticeable in family 2, where the mother noted poorer
functioning of her son with FAP compared to her son
without FAP (as evidenced by a difference in greater
than one standard deviation) in five of the eight domains
measured. Figure 3 shows the results of mothers’ ratings
of behavior and social-emotional characteristics as mea-
sured by the ABCL/18-59. In Families 1 and 2, there was
a consistent trend towards the mothers’ rating their
child with FAP with poorer function than their child
without FAP on all aspects tested.
Results of MRI
The diffusion numbers in multiple regions of the brains
showed no difference in the white matter metrics in all
three pairs between the FAP patients and non-FAP sib-
lings. No differences were detected using diffusion ten-
sor imaging analysis.
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Discussion
We report the first study exploring neuropsychological,
social-emotional, and structural brain characteristics of
patients with FAP. Based on informal clinical observa-
tion, we expected within-pair differences favoring im-
proved function in the non-FAP sibling across many
domains. However, we found differences in only a subset
of the measured parameters. Compared to sex-matched
siblings of similar age with negative germline mutations
for FAP, two of the three patients with FAP were rated
by their mothers as showing more problematic behav-
ioral and social-emotional characteristics. In contrast,
there were similarities on the many measures of neuro-
psychological functioning (general intelligence, executive
function, and basic academic skills) tested by the blinded
psychologist and on ratings of skills of daily life by the
mothers. These results do not fully support our hypoth-
esis that patients with FAP would show poorer function-
ing compared to their unaffected siblings.
There is a biological basis for the role of APC in neuro-
cognitive development. APC expression by adult neural
stem cells is a critical component of adult neurogenesis in
mice through regulation of intracellular β -catenin levels
[13] and lack of APC induces severe laminary defects in
some regions of the mouse brain, including the cerebral
cortex, hippocampus, olfactory bulbs and cerebellum [11].
Additionally, APC is required for multiple aspects of early
cerebral cortical development in mice, including the regu-
lation of cell number, interkinetic nuclear migration, cell
polarity and cell type specification [12]. Furthermore, APC
mutant mice have abnormal brain function and behavior
including depression-like behavior and decreased social
interaction [16] as well as autistic-like behaviors as mani-
fested by increased repetitive behaviors and reduced social
interest [17]. Studies in humans have thus far been limited
to case reports, including a patient with FAP secondary to
deletion of the entire long arm of chromosome 5 leading
to a phenotype of FAP with features of Prader-Wili Syn-
drome [4] and another patient with deletion of the entire
APC gene through loss of 5q21-22 with the classic FAP
phenotype along with intellectual disability and dys-
morphic features [5]. In contrast to the animal studies that
have shown abnormal neurocognitive development in
APC-mutant mice and limited case reports in humans,
Fig. 1 Pedigree for each family
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the results of this study show no systematic deficits in pa-
tients with FAP compared to their non-FAP siblings in
performance on neuropsychological tests, suggesting a
possible compensatory genetic mechanism in humans that
leads to a normal neurocognitive phenotype.
There were many strengths to the study design that
deserve mention. First, the paired-sibling design was an
efficient and natural study design that allowed for con-
trol over the environment in which the paired subjects
were raised and therefore accounted at least partially for
this potential confounder. Second, multiple aspects of
neurocognitive functioning were assessed with validated
and accepted neuropsychological tests addressing mul-
tiple domains; widely-used and accepted rating question-
naires allowed the mothers to describe their children’s
typical behavior in natural settings of home and school,
with family and friends, and MRI was utilized to assess
brain structure. Third, a single psychologist administered
all of the neuropsychological tests to all the patients and
their siblings and she was blinded to their medical status
(FAP or non-FAP), which also allowed for mitigation of
potential observer bias. There was potential for bias to
have accounted for the differences identified between
sibling pairs by the mothers’ rating, given the mother
had knowledge of whether her children had FAP. In two
of these families, the children were diagnosed at a young
age and this may have not only affected the mother’s
perception of her child but may have affected the treat-
ment of the child growing up as a result of the diagnosis
which may have affected the patient’s behavior and social
skills.
The major limitation of the study was the small sample
size, which could not provide sufficient power to detect a
difference. The aim was to carry out a pilot study and we
found that the study was feasible. It is possible that differ-
ences in cognitive phenotype do exist but were not
assessed in the validated measures s utilized in this study.
Given the well-accepted and widely available measures
Fig. 2 Differences in results of neuropsychological and adaptive life skills testing. VCI-Verbal Comprehension Index; PRI-Perceptual Reasoning
Index; FSIQ4-Full Scale Intelligence Quotient of all 4 subtests
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and methods used in this study, this template could be
adopted in a larger study, which would have greater power
to detect any significant differences.
Conclusions
Our pilot study did not detect differences on a variety of
neurocognitive skills or in brain structure as assessed by
MRI in patients with FAP compared to their unaffected
siblings. However, a pattern of poorer functioning of the
FAP patients in social and emotional characteristics as
rated by their mothers was identified. The study was
underpowered to detect significant differences. Further re-
search with a larger sample of matched pairs is needed to
elucidate the relationship, if any, between FAP and the de-
velopment of the brain and on cognitive skills and on
social-emotional behaviors. Our preliminary data suggest
that it may be worthwhile to focus on measures of social-
emotional functioning in planning future studies.
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